Results 31 to 40 of about 517,509 (243)
COVID-19-Associated severe autoimmune hemolytic anemia: A rare case report
Autoimmune hemolytic anemia (AIHA) is a very rare presentation of COVID-19, and AIHA due to COVID-19 alone (i.e., in the absence of an associated underlying disorder) is extremely rare. Warm agglutinin disease accounts for the majority of AIHA in general.
Lakshmi J Nair +2 more
doaj +1 more source
Objective Glycosylphosphatidylinositol (GPI)‐anchored proteins play critical roles in nervous system function. Pathogenic variants in genes involved in GPI‐anchor biosynthesis cause early‐onset multisystem disorders known as inherited GPI deficiencies. We describe a novel neuromuscular phenotype associated with PIGB deficiency.
Gorka Fernández‐Eulate +34 more
wiley +1 more source
Venetoclax, a BCL-2 inhibitor used in chronic lymphocytic leukemia and acute myeloid leukemia, has been rarely associated with autoimmune hemolytic anemia, mostly in chronic lymphocytic leukemia.
Karima Benallaoua +4 more
doaj +1 more source
Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia
Autoimmune hemolytic anemia is a rare condition characterized by destruction of red blood cells with and without involvement of complement. It is associated with significant morbidity and mortality.
Irina Murakhovskaya
core +1 more source
From Interferon Signature to the Clinical Landscape: Type I Interferonopathies
Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz +13 more
wiley +1 more source
Autoimmune Hemolytic Anemia in a Dog [PDF]
Autoimmune Hemolytic Anemia is a naturally occurring disease of dogs characterized usually by thrombocytopenia, hemolytic anemia, reticulocytosis, and a positive direct anti-globulin test (Coomb's test).
Bryan, Joseph
core
Ceftriaxone‐associated immune haemolytic anaemia: A patient‐level systematic review
Abstract Ceftriaxone can cause acute haemolysis. Its clinical presentation, risk factors, and outcomes remain incompletely characterized. We conducted a systematic review of published cases with patient‐level data, following international guidelines and with registration in PROSPERO (CRD420261338709). Reports were identified through three bibliographic
Sonja Miotti +9 more
wiley +1 more source
Undetectable Glycosylated Hemoglobin in Autoimmune Hemolytic Anemia [PDF]
We encountered two cases of autoimmune hemolytic anemia (AIHA) with undetectable glycosylated hemoglobin (HbA1C) level at diagnosis.
Mitani, Noriyuki +6 more
core
Idiopathic intracranial hypertension with autoimmune hemolytic anemia: A rare association
Background: Autoimmune hemolytic anemia (AIHA) is an acquired form of immune-mediated hemolytic anemia. Association of idiopathic intracranial hypertension (IIH) has been observed with iron deficiency anemia, parvovirus B-19 associated anemia, and ...
Jasmine Singh +3 more
doaj +1 more source
Durable responses in refractory autoimmune hemolytic anemia with alemtuzumab
Autoimmune hemolytic anemia occurs due to an interaction of IgG antibodies with protein antigens expressed on red blood corpuscles. Glucocorticoids are the mainstay of treatment for autoimmune hemolytic anemia.
Renee K McAlister +2 more
core +1 more source

